Inventor
PINCHUK ANATOLY
US30 patents
⚠️ This page may combine multiple inventors who share the name “PINCHUK ANATOLY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WISCONSIN ALUMNI RES FOUND
11 patentsUS10813998B2Oct 27, 2020
Long-lived gadolinium based tumor targeting imaging and therapy agents
WISCONSIN ALUMNI RES FOUND5 citations82
US10265398B2Apr 23, 2019
Long-lived gadolinium based tumor targeted imaging and therapy agents
WISCONSIN ALUMNI RES FOUND5 citations81
US11623007B2Apr 11, 2023
Long-lived gadolinium based tumor targeted imaging and therapy agents
WISCONSIN ALUMNI RES FOUND3 citations71
US11730834B2Aug 22, 2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination
WISCONSIN ALUMNI RES FOUND3 citations70
US11186598B2Nov 30, 2021
Radioactive phospholipid metal chelates for cancer imaging and therapy
WISCONSIN ALUMNI RES FOUND4 citations70
US10751430B2Aug 25, 2020
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination
WISCONSIN ALUMNI RES FOUND3 citations70
US10736949B2Aug 11, 2020
Radiohalogenated agents for in situ immune modulated cancer vaccination
WISCONSIN ALUMNI RES FOUND2 citations69
US12564635B2Mar 3, 2026
Long-lived gadolinium based tumor targeted imaging and therapy agents
WISCONSIN ALUMNI RES FOUND0 citations61
US12318458B2Jun 3, 2025
PSMA-targeting ligands with optimal properties for imaging and therapy
WISCONSIN ALUMNI RES FOUND0 citations59
US12156921B2Dec 3, 2024
PSMA-targeting ligands with optimal properties for imaging and therapy
WISCONSIN ALUMNI RES FOUND0 citations59
US12109256B2Oct 8, 2024
Radiohalogenated agents for in situ immune modulated cancer vaccination
WISCONSIN ALUMNI RES FOUND0 citations59
CELLECTAR INC
10 patentsUS8877159B2Nov 4, 2014
Phospholipid analogs as diapeutic agents and methods thereof
CELLECTAR INC14 citations92
US8877160B2Nov 4, 2014
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
CELLECTAR INC11 citations84
US8022235B2Sep 20, 2011
Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use
CELLECTAR INC12 citations84
US7893286B2Feb 22, 2011
Method for the synthesis of phospholipid ethers
CELLECTAR INC17 citations84
US9339564B2May 17, 2016
Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer
CELLECTAR INC7 citations82
US7811548B1Oct 12, 2010
Fluorescent phospholipid ether compounds and compositions
CELLECTAR INC16 citations82
US9550002B2Jan 24, 2017
Phospholipid analogs as diapeutic agents and methods thereof
CELLECTAR INC3 citations73
US10004818B2Jun 26, 2018
Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer
CELLECTAR INC2 citations71
US9616140B2Apr 11, 2017
Fluorescent phospholipid ether compounds, compositions, and methods of use
CELLECTAR INC2 citations71
US9579406B2Feb 28, 2017
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
CELLECTAR INC0 citations52
CELLECTAR BIOSCIENCES INC
5 patentsUS9480754B2Nov 1, 2016
Phospholipid ether analogs as cancer-targeting drug vehicles
CELLECTAR BIOSCIENCES INC11 citations89
US9345718B1May 24, 2016
Phospholipid ether analogs as cancer-targeting drug vehicles
CELLECTAR BIOSCIENCES INC12 citations89
US9925269B2Mar 27, 2018
Phospholipid ether analogs as cancer-targeting drug vehicles
CELLECTAR BIOSCIENCES INC4 citations81
US11467159B2Oct 11, 2022
Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells
CELLECTAR BIOSCIENCES INC0 citations60
US11439709B2Sep 13, 2022
Phospholipid ether analogs as cancer-targeting drug vehicles
CELLECTAR BIOSCIENCES INC0 citations59